André Archimbaud
Keine laufenden Positionen mehr
Profil
André Archimbaud formerly worked at Kinetek Pharmaceuticals, Inc., as President & Chief Executive Officer from 1998 to 2004, BioSyntech, Inc., as Chairman, CryoCath Technologies, Inc., as Director in 2006, Medicago, Inc., as Director, Mirati Therapeutics, Inc., as Director from 2009 to 2011, BioArtificial Gel Technologies, Inc., as Director in 2008, MedMira, Inc., as Director from 2009 to 2011, GeneOhm Sciences, Inc., as Senior Vice President, and Société Générale de Financement du Québec, as Group Vice President.
Mr. Archimbaud received his undergraduate degree from Institut d'Études Politiques d'Aix-en-Provence.
Ehemalige bekannte Positionen von André Archimbaud
| Unternehmen | Position | Ende |
|---|---|---|
| MEDMIRA INC. | Direktor/Vorstandsmitglied | 27.01.2011 |
BioArtificial Gel Technologies, Inc.
 BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | 21.10.2008 |
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Direktor/Vorstandsmitglied | 01.01.2006 |
| Kinetek Pharmaceuticals, Inc. | Präsident | 01.01.2004 |
| MIRATI THERAPEUTICS | Direktor/Vorstandsmitglied | 14.06.2011 |
Ausbildung von André Archimbaud
| Institut d'Études Politiques d'Aix-en-Provence | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOSYNTECH, INC. | Health Technology |
| MEDMIRA INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
Société Générale de Financement du Québec
 Société Générale de Financement du Québec Investment ManagersFinance A department of the province of Québec, the Société Générale de Financement du Québec (SGF) provides development capital for businesses. They are headquartered in Montreal with offices in Québec and Saint-Hyacinthe. The firm was founded in 1962. | Finance |
| Kinetek Pharmaceuticals, Inc. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Health Technology |